DFTXNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Definium Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$32.97+0.87 (+2.71%)
Close on Oct 19, 2026
- Market cap
- $3.65B
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about Definium Therapeutics from other investors
No posts about DFTX yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.